Lesson plan

KM-391

KM-391 is a serotonin reuptake inhibitor which was under development for the treatment of autism but was never marketed. It is taken by mouth.

Back to article

Article summary

KM-391 is a serotonin reuptake inhibitor which was under development for the treatment of autism but was never marketed. It is taken by mouth.

Key claims

No claims recorded.

Discussion questions

  1. Summarise the article in your own words. Which single claim would you verify first, and why?
  2. Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
  3. If two sources disagreed about one of these facts, what would you need in order to trust one over the other?

Bibliography

No sources recorded.

Key claims and bibliography are generated from the same tracked claims and sources as the article page.